Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Hikal Ltd

    Hikal Ltd was incorporated by the Hiremath family on July 8, 1988 as a private limited company, Hikal Chemicals Industries Private limited. The Hiremath family and Surajmukhi In

  • No Image
    Himalaya Global Holdings Ltd

    Himalaya Global Holdings Ltd was established in 1930, is a closely held Bangalore-based partnership firm, the partners being HGH, a company registered at Cayman Islands and HD

  • No Image
    Hiran Orgochem Ltd

    Incorporated in 1983, Mumbai based Hiran Orgochem Ltd is a integrated manufacturer of active pharmaceutical ingredients and formulations. It has focused on Manufacturing the Qui

  • No Image
    HLL Lifecare Ltd

    HLL Lifecare Ltd is a 100% Government of India owned entity was incorporated in 1966 for the production of male contraceptive sheaths and commenced operations

  • No Image
    Huvepharma Sea Pvt Ltd

    Huvepharma is a fast-growing global pharmaceutical company with focus on developing, manufacturing and marketing of human and animal health products.